SGFG
AMGN icon

Silver Grove Financial Group’s Amgen AMGN Stock Holding History

Silver Grove Financial Group’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$152K Buy
420
+407
+3,131% +$139K 0.08% 175
2026
Q1 		$4.58K Buy
+13
New +$4.63K ﹤0.01% 364

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Silver Grove Financial Group's AMGN Position: Q2 2026 in Review

Silver Grove Financial Group increased its Amgen (AMGN) stake by 3,131% in Q2 2026, buying an estimated $139K and bringing the position to 420 shares worth $152K. The position accounts for 0.08% of the portfolio, ranked #175.

Silver Grove Financial Group first reported a position in AMGN in Q1 2026 and has held it in 2 quarters since. 3,137 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Silver Grove Financial Group held 420 shares of Amgen worth $152K as of Q2 2026.
  • Silver Grove Financial Group bought 407 Amgen shares in Q2 2026, an estimated $139K.
  • Amgen made up 0.08% of Silver Grove Financial Group's portfolio in Q2 2026, its #175 holding.
  • Silver Grove Financial Group first reported a position in Amgen in Q1 2026 and has held it in 2 quarters since.
  • 3,137 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Silver Grove Financial Group's 13F filing for Q2 2026, filed 13 Aug 2026.